Multi-level Governance and the Way Forward for European Drug Policy

Abstract

To date, the prognosis for harmonization of drug policy within the EU is not particularly positive. Two main obstacles to achieving this goal remain: the inability of the EU to decide in favour of either a liberal or a restrictive drug policy and the development of very varied styles of drug policy at the national level, in combination with a high degree of national attachment to individual policy practices. This final chapter seeks to summarize the arguments presented thus far on both the desirability and the viability of a harmonized European drug policy, to examine the various forms that such a policy could take and, finally, to propose a system of harmonization based on the principles of subsidiarity and multi-level governance which were outlined in the first chapter of this book.KeywordsMember StateDrug UserIllicit DrugOrganize CrimeHarm ReductionThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.